Novavax’s stock soars 51% after positive COVID and flu trial data and news of plan to lay off 25% of workforce

The news helped ease fears raised by the company's "going-concern" language earlier this year.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.